Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 39.34 yuan, reflecting a 3.96% increase as of January 5, 2026, with significant trading activity noted [1]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a main revenue of 7.897 billion yuan, representing a year-on-year increase of 30.1% [2]. - The net profit attributable to shareholders reached 732 million yuan, up 32.36% year-on-year, while the net profit excluding non-recurring items was 679 million yuan, marking a 43.93% increase [2]. - In Q3 2025 alone, the company achieved a quarterly main revenue of 2.601 billion yuan, a 27.71% increase year-on-year, with a quarterly net profit of 240 million yuan, reflecting a 42.11% rise [2]. - The company's debt ratio stands at 33.87%, with investment income of 33.23 million yuan and financial expenses of -2.036 million yuan, alongside a gross profit margin of 48.32% [2]. Market Sentiment - Over the past 90 days, 21 institutions have provided ratings for Steady Medical, with 17 recommending a buy and 4 suggesting an increase in holdings [2]. - The average target price set by institutions for the stock over the last 90 days is 5.488 billion yuan [2].
股票行情快报:稳健医疗(300888)1月5日主力资金净卖出70.68万元